4-Biphenylcarboxylic Acid (CAS 92-92-2): Sourcing a Pharma Intermediate That Tolerates No Impurity Surprises

⇒What This Article Covers: Why pharmaceutical buyers face stricter requirements for biphenyl intermediates. Typical applications and what spec to request. Supply chain structure in China. What sdlookchem provides and how to set up a qualification process. Common sourcing mistakes. 

4-Biphenylcarboxylic Acid

Get One-Stop Solution from This Page

A Specification Issue That Derailed a Drug Development Timeline

A small pharma company in Germany sourcing 4-Biphenylcarboxylic Acid (CAS 92-92-2) for an early-stage API synthesis project ran into a problem that’s more common than it should be. Their process was sensitive to biphenyl isomer contamination — specifically 2-biphenylcarboxylic acid (the ortho isomer). The supplier’s CoA showed 99% purity. It didn’t specify which isomer test was being used or what the ortho isomer limit was.
 
The batch came in with ortho isomer at 0.6%. That number wasn’t on the CoA because it wasn’t tested for. In their synthesis route, it caused an unexpected side reaction that took two months of method development to diagnose. The cost in time was significant. The cost in trust with the CRO they were working with was harder to measure.
 
The fix was simple: specify the isomer purity explicitly and require HPLC analysis with isomer separation. The problem was that nobody asked the right question upfront.

Market Context: Where This Compound Fits

4-Biphenylcarboxylic Acid is an intermediate used primarily in pharmaceutical synthesis and specialty polymer chemistry. On the pharma side, the biphenyl scaffold appears in multiple drug structures across cardiovascular, oncology, and CNS therapeutic areas. Demand from pharma buyers is relatively stable but specification requirements are high and qualification cycles are long.
 
In specialty materials, it’s used as a monomer or intermediate in liquid crystal polymers (LCP) and polyester synthesis. The demand from this segment has been growing with electronics miniaturization — LCP is increasingly used in 5G antenna components and high-frequency PCB applications.
 
Chinese supply dominates globally. Shandong and Jiangsu are the main production regions. The gap between suppliers serving pharma-grade downstream and those primarily serving polymer or general chemical markets shows up clearly in documentation quality and isomer control.

Applications and What Spec Actually Matters

For pharmaceutical synthesis applications, the critical parameters are: HPLC purity ≥ 99.0% with isomer separation, specific impurity limits for ortho and meta isomers, residual solvent compliance per ICH Q3C, and a full impurity profile rather than a single purity number. Heavy metals testing is typically required for drug substance intermediates.
 
For polymer/LCP applications, the main requirements are different: melting point consistency, carboxylic acid functionality (acid value), and low color. The color spec matters because it affects the final polymer’s optical properties. A slightly discolored batch of 4-Biphenylcarboxylic Acid can affect the downstream product’s appearance or performance.
 
Reference standard applications — analytical chemistry, method development, regulatory submissions — require the strictest specs of all: HPLC purity ≥ 99.5%, a certificate traceable to a pharmacopeial standard, and individual known impurity identification with explicit limits.
 
4-Biphenylcarboxylic Acid

sdlookchem: Supply Capacity and Quality Systems

Shandong Lookchemical produces 4-Biphenylcarboxylic Acid with dedicated synthesis capacity and a quality system that includes HPLC-based purity testing with isomer resolution, melting point confirmation, and heavy metals screening as standard release tests. This is not a spot-sourced product — it’s manufactured in recurring batches with full traceability.
 
For pharmaceutical customers, the factory provides batch-specific CoAs with full test data, GHS-compliant SDS/MSDS for both EU CLP and US GHS formats, and DMF support documentation on request. The qualification package is designed for buyers who need to document their supplier as part of their own quality management system.
 
Export documentation is prepared correctly for this compound class, including accurate HS code assignment and hazardous goods declarations where required. Buyers who’ve had problems with customs delays due to incomplete paperwork — and this is more common than it should be — will find the documentation level here more complete than typical Chinese trading company supply.
 
Minimum order is 1 kg. Larger quantities available from stock or with 10–15 business day lead time for manufactured-to-order batches.

How to Run the Qualification Without Wasting Three Months

Step one: write a clear incoming material spec before you contact any supplier. It should state HPLC purity method, the specific impurities you’re controlling for (isomers by name), residual solvent class limits, and the documentation you need at delivery. If you don’t have this written down, every supplier will interpret ‘high purity’ differently.
 
Step two: request a 100 g sample and test it against your spec before placing any bulk order. This sounds obvious. It gets skipped when timelines are tight and buyers are overconfident. The two-month delay in the example above was entirely avoidable if this step had happened.
 
Step three: review the SDS/MSDS for transport compliance. 4-Biphenylcarboxylic Acid has specific transport requirements under IMDG. Your freight forwarder needs the correct UN number, packing group, and flash point data. Confirm these before booking shipment.
 
Step four: establish a retained sample protocol. For any lot you use in pharmaceutical or specialty polymer synthesis, get a confirmed retained sample at the supplier. You’ll want it if any quality issue surfaces six months later.

Mistakes That Cost Real Money

Specifying only assay without isomer control. In biphenyl chemistry, the positional isomers co-elute on some analytical methods. A 99% assay result can mask significant isomer contamination if the method isn’t designed to resolve them.
 
Treating pharma-intermediate procurement the same as general chemical procurement. The documentation requirements, quality system expectations, and impurity control standards are fundamentally different. Suppliers who primarily serve industrial markets often can’t meet pharma intermediate requirements even if the purity number looks the same.
 
Not planning for GMP documentation if the downstream use is regulated. If your 4-Biphenylcarboxylic Acid ends up in a drug substance, your supplier qualification documentation needs to support an audit. Trading companies typically can’t provide this.

Bottom Line

4-Biphenylcarboxylic Acid (CAS 92-92-2) is a compound where the gap between ‘good enough’ and ‘right for your application’ is meaningful. The impurity profile matters as much as the headline purity. Getting it right requires specifying correctly from the start and buying from a supplier with the analytical capability to confirm compliance.
 

Related News Recommendations

Our Factory Equipment